{ "case_number": "CAC-UDRP-108907", "time_of_filling": "2026-08-06 10:35:59", "domain_names": [ "frontlineplus-spot-on.store" ], "case_administrator": " Iveta Špiclová (Czech Arbitration Court) (Case admin)", "complainant": [ "Boehringer Ingelheim Animal Health France " ], "complainant_representative": "NAMESHIELD S.A.S.", "respondent": [ "jason roy" ], "respondent_representative": null, "factual_background": "

Boehringer Ingelheim Animal Health France (“Boehringer Ingelheim” or “Complainant”) is part of the Boehringer Ingelheim group, a global leader in the animal health industry founded in 1885. The Complainant markets FRONTLINE, a line of veterinary antiparasitic products indicated for the treatment and prevention of fleas, ticks and chewing lice in dogs and cats, with the FRONTLINE PLUS variant additionally breaking the flea life cycle by preventing the development of immature stages.<\/p>\n

The Complainant is marketing its goods online through the domain name <frontline.com>, registered on January 28, 1999.<\/p>\n

The disputed domain name <frontlineplus-spot-on.store> was registered on May 28, 2026, and resolves to a website offering for sale products bearing the Complainant's FRONTLINE mark.<\/span><\/p>", "other_legal_proceedings": "

The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "

The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.
No administratively compliant Response has been filed.<\/p>", "rights": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "

The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "

The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Darius Sauliūnas" ], "date_of_panel_decision": "2026-09-16 00:00:00", "informal_english_translation": "

The Complainant owns a portfolio of trademark registrations for FRONTLINE, including the international trademark FRONTLINE No. 621912, registered since June 9, 1994, covering veterinary antiparasitic products in class 5, and the international trademark FRONTLINE No. 1245236, registered since January 30, 2015, covering veterinary and cosmetic products in classes 3 and 5.<\/span><\/div>\n
<\/div>", "decision_domains": { "frontlineplus-spot-on.store": "TRANSFERRED" }, "panelist": null, "panellists_text": null }